The FDA announced that it will now require Botox and its progeny to provide black-box warning. The FDA said the labeling is necessary to warn doctors and patients that Botox has potentially fatal complications, including problems with swallowing or breathing. The FDA has identified at least 225 reports of medical problems among patients treated with Botox and similar drugs.
If there was a stock available in 2004 called “The FDA Will Eventually Require Black Box Warnings for Boxtox But It Will Take Awhile”, I would have bought a ton of it. Unbelievably predictable.